Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy

Blood

Volumn 96, Issue 1, 2000, Pages 76-79

  Harmatz, Paul ^a   Butensky, Ellen ^b   Quirolo, Keith ^b   Williams, Roger ^b   Ferrell, Linda ^b   Moyer, Thomas ^b   Golden, Daniel ^b   Neumayr, Lynne ^b   Vichinsky, Elliott ^b  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN S; IRON;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC VALUE; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FERRITIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON CHELATION; IRON OVERLOAD; IRON THERAPY; LIVER BIOPSY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SCORING SYSTEM; SICKLE CELL ANEMIA;

EID: 0034235835     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.1.76     Document Type: Article

References (18)

1. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5-11.
2. Files B, Brambilla D, Kutlar A, et al. A randomized trial of chronic transfusion to prevent stroke in sickle cell anemia: changes in ferritin with chronic transfusion. Blood. 1999;92:528a.
3. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110:1107-1119.
4. Brittenham GM, Griffith PM, Nienhuis AW, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med. 1994;331:567-573.
5. Deugnier YM, Loreal O, Turlin B, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology. 1992;102:2050-2059.
6. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology. 1993; 105:274-278.
7. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513-1520.
8. Cohen A, Gayer R, Mizanin J. Long-term effect of splenectomy on transfusion requirements in thalassemia major. Am J Hematol. 1989;30:254-256.
9. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89:739-761.
10. Cohen A, Kron E, Brittenham GM. Toxicity of transfusional iron overload in sickle cell anemia. Blood. 1984;64:47a.
11. Brittenham GM, Cohen AR, McLaren CE, et al. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol. 1993;42:81-85.
12. Worwood M, Cragg SJ, Jacobs A, McLaren C, Ricketts C, Economidou J. Binding of serum ferritin to concanavalin A: patients with homozygous B thalassemia and transfusional iron overload. Br J Haematol. 1980;46:409-416.
13. Gungor T, Rohrbach E, Solem E, Kaltwasser JP, Kornhuber B. Logarithmic quantitation model using serum ferritin to estimate iron overload in secondary haemochromatosis. Arch Dis Child. 1996; 74:323-327.
14. Mandishona E, MacPhail AP, Gordeuk VR, et al. Dietary iron overload as a risk factor for hepatocellular carcinoma in black Africans. Hepatology. 1998;27:1563-1566.
15. Turfin B, Deugnier Y. Evaluation and interpretation of iron in the liver. Semin Diagn Pathol. 1998; 15:237-245.
16. Bothwell TH, Charlton RW, Cook JD, Finch CA. Iron Metabolism in Man. Oxford, UK: Blackwell Scientific Publications; 1979.
17. Vatanavicharn S, Anuwatanakulchai M, Tuntawiroon M, Suwanik R, Wasi P. Iron absorption in patients with beta-thalassemia/haemoglobin disease and the effect of splenectomy. Acta Haematol. 1983;69:414-416.
18. Angelucci E, Baronciani D, Lucarelli G, et al. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol 1995;89:757-761.